An ambitious new international collaboration, bolstered by a prestigious pan-European EUREKA grant, is set to revolutionize the treatment landscape for…
Read More
Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
A groundbreaking international collaboration, fortified by a prestigious pan-European EUREKA grant, has been officially launched to pioneer the development of…
Read More
Molecular Mapping of Bone Marrow Remodeling Reveals Early Inflammatory Drivers of Blood Cancer and Myelodysplastic Syndrome
The human bone marrow is one of the most industrious environments in the human body, a cellular factory that generates…
Read More
Rubedo Life Sciences Pioneers Senolytic Approach to Reverse Skin Aging and Treat Inflammatory Dermatoses
In a significant shift within the pharmaceutical and longevity sectors, Rubedo Life Sciences, under the leadership of CEO Dr. Frederick…
Read More
Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
A groundbreaking international collaboration, bolstered by a prestigious pan-European EUREKA grant, has been officially announced, aiming to pioneer the development…
Read More
Inflammatory Remodeling of the Bone Marrow Microenvironment Identified as a Precursor to Myeloid Malignancies
The human bone marrow is a site of frantic, precision-engineered biological activity, responsible for the generation of millions of new…
Read More
